Notice2022-18000
National Institute of Allergy and Infectious Diseases; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
August 22, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 161 (Monday, August 22, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 161 (Monday, August 22, 2022)]
[Notices]
[Page 51437]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-18000]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The contract proposals and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases, Special Emphasis Panel; Development of Medical
Countermeasures for Biothreat Agents, Antimicrobial-Resistant
Infections and Emerging Infectious Diseases; Research Area 002--
Development of Therapeutic Candidates for Biodefense, Antimicrobial
Resistant (AMR) Infect.
Date: September 7-8, 2022.
Time: 10 a.m. to 2 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mohammed S. Aiyegbo, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20852, (301) 761-7106, <a href="/cdn-cgi/l/email-protection#fc9193949d91919998d29d9585999b9e93bc929594d29b938a"><span class="__cf_email__" data-cfemail="107d7f78717d7d75743e7179697577727f507e79783e777f66">[email protected]</span></a>.
Name of Committee: National Institute of Allergy and Infectious
Diseases, Special Emphasis Panel; NIAID 2022 Omnibus BAA (HHS-NIH-
NIAID-BAA2022-1) Research Area 002: Development of Therapeutic
Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections
and Emerging Infectious Diseases (N01).
Date: September 13-14, 2022.
Time: 10 a.m. to 5 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Mohammed S. Aiyegbo, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3E70,
Rockville, MD 20852, (301) 761-7106, <a href="/cdn-cgi/l/email-protection#dbb6b4b3bab6b6bebff5bab2a2bebcb9b49bb5b2b3f5bcb4ad"><span class="__cf_email__" data-cfemail="b2dfdddad3dfdfd7d69cd3dbcbd7d5d0ddf2dcdbda9cd5ddc4">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: August 16, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-18000 Filed 8-19-22; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on August 22, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.